Literature DB >> 32107325

Clinical Reasoning: A 45-year-old man with progressive insomnia and psychiatric and motor symptoms.

José Eduardo E Lima1, Teddy S Youn1, Christopher Robinson1, Emily J Gilmore1, Matthew Schrag1, Sirisha Sanamandra1, Carolina B Maciel2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32107325      PMCID: PMC7220232          DOI: 10.1212/WNL.0000000000009098

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   11.800


× No keyword cloud information.
  10 in total

1.  Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies.

Authors:  Pietro Cortelli; Daniela Perani; Pasquale Montagna; Roberto Gallassi; Paolo Tinuper; Federica Provini; Provini Federica; Patrizia Avoni; Franco Ferrillo; Davide Anchisi; Rosa Maria Moresco; Ferruccio Fazio; Piero Parchi; Agostino Baruzzi; Elio Lugaresi; Pierluigi Gambetti
Journal:  Brain       Date:  2006-01-06       Impact factor: 13.501

2.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

Review 3.  Familial and sporadic fatal insomnia.

Authors:  Pasquale Montagna; Pierluigi Gambetti; Pietro Cortelli; Elio Lugaresi
Journal:  Lancet Neurol       Date:  2003-03       Impact factor: 44.182

4.  Clinical, histopathological and genetic studies in a family with fatal familial insomnia.

Authors:  Xiao-Hong Shi; Jun Han; Jin Zhang; Qi Shi; Jian-Ming Chen; Sheng-Li Xia; Zhi-Qiang Xie; Xiao-Jing Shen; Bing Shan; Yan-Jun Lei; Song Shi; Wei Zhou; Bao-Yun Zhang; Chen Gao; Ying-Hui Liu; Juan Song; Yan-Jun Guo; De-Xin Wang; Bian-Li Xu; Xiao-Ping Dong
Journal:  Infect Genet Evol       Date:  2010-01-22       Impact factor: 3.342

5.  The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies.

Authors:  Agnes van Sonderen; Marco W J Schreurs; Marienke A A M de Bruijn; Sanae Boukhrissi; Mariska M P Nagtzaam; Esther S P Hulsenboom; Roelien H Enting; Roland D Thijs; Paul W Wirtz; Peter A E Sillevis Smitt; Maarten J Titulaer
Journal:  Neurology       Date:  2016-04-01       Impact factor: 9.910

6.  Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort.

Authors:  Woo-Jin Lee; Soon-Tae Lee; Jung-Ick Byun; Jun-Sang Sunwoo; Tae-Joon Kim; Jung-Ah Lim; Jangsup Moon; Han Sang Lee; Yong-Won Shin; Keon-Joo Lee; Soyun Kim; Keun-Hwa Jung; Ki-Young Jung; Kon Chu; Sang Kun Lee
Journal:  Neurology       Date:  2016-04-01       Impact factor: 9.910

7.  Clinical features of fatal familial insomnia: phenotypic variability in relation to a polymorphism at codon 129 of the prion protein gene.

Authors:  P Montagna; P Cortelli; P Avoni; P Tinuper; G Plazzi; R Gallassi; F Portaluppi; J Julien; C Vital; M B Delisle; P Gambetti; E Lugaresi
Journal:  Brain Pathol       Date:  1998-07       Impact factor: 6.508

8.  Sporadic fatal insomnia in a young woman: a diagnostic challenge: case report.

Authors:  Karen M Moody; Lawrence B Schonberger; Ryan A Maddox; Wen-Quan Zou; Laura Cracco; Ignazio Cali
Journal:  BMC Neurol       Date:  2011-10-31       Impact factor: 2.474

9.  The Features of Genetic Prion Diseases Based on Chinese Surveillance Program.

Authors:  Qi Shi; Wei Zhou; Cao Chen; Bao-Yun Zhang; Kang Xiao; Xiu-Chun Zhang; Xiao-Jing Shen; Qing Li; Li-Quan Deng; Jian-Hua Dong; Wen-Qing Lin; Pu Huang; Wei-Jia Jiang; Jie Lv; Jun Han; Xiao-Ping Dong
Journal:  PLoS One       Date:  2015-10-21       Impact factor: 3.240

Review 10.  Treatment strategies for autoimmune encephalitis.

Authors:  Yong-Won Shin; Soon-Tae Lee; Kyung-Il Park; Keun-Hwa Jung; Ki-Young Jung; Sang Kun Lee; Kon Chu
Journal:  Ther Adv Neurol Disord       Date:  2017-08-16       Impact factor: 6.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.